Skip links

Computer System Validation (CSV) in Pharma Manufacturing

Increasingly, every batch a pharmaceutical manufacturer releases today is, in part, a product of software. Recipe management systems, MES platforms, LIMS, building management systems, and the dozens of other computerized systems running on a shop floor all influence whether that batch was made correctly and whether the records proving it can be trusted.

Computer System Validation (CSV) is the discipline that gives manufacturers and regulators confidence in those systems. Done well, it’s a quality safeguard. Done badly, it’s a paperwork exercise that consumes enormous time without adding real assurance.

This article covers what CSV is, why it matters specifically in life sciences manufacturing, and how a modern, risk-based approach differs from the legacy way it’s often still practiced.

In this article

What is Computer System Validation (CSV)?

Computer System Validation is the documented process of establishing, with a high degree of assurance, that a computerized system used in a GxP-regulated environment consistently performs as intended, accurately and reliably, and in compliance with applicable regulations.

CSV applies to any system that affects product quality, patient safety, or the integrity of GxP records such as Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Enterprise Resource Planning (ERP) systems, Quality Management Systems (QMS), building management and environmental monitoring systems, and even spreadsheets used for GxP calculations.

The traditional approach to CSV follows an IQ/OQ/PQ structure inherited from equipment qualification:

  • Installation Qualification (IQ)

confirms the system has been installed correctly, in line with its specifications.

  • Operational Qualification (OQ)

confirms the system operates as intended across its functional range.

  • Performance Qualification (PQ)

confirms the system performs reliably under real-world operating conditions, with real users and real data.

This structure and terminology is referenced throughout the industry, but it’s important to understand it was designed for physical equipment, not software and that recent guidance supports alternative terms that are more typical for software development.

A point that becomes significant when scoping how much testing a computer system genuinely needs, what has already been Qualified by the supplier, and using risk which areas are in scope for Validation.

Core principles of Computer System Validation

Regardless of system type, scale, or deployment model, a handful of core principles underpin sound CSV:

  • Risk-based approach.

Validation effort should be proportionate to GxP criticality and patient safety impact, not applied uniformly to every system or function.

  • Data integrity by design.

Systems should be assessed against ALCOA+ principles from the earliest design stages, not retrofitted during testing.

  • Lifecycle thinking.

Validation spans the full system lifecycle, from requirements and design through testing, deployment, and ongoing operation.

  • Defined roles and accountability.

Clear ownership of who prepares, reviews, and approves each deliverable; accountability to the regulator stays with the user.

  • Traceability.

    Every requirement should trace forward to a design element and a test case, typically via a Requirements Traceability Matrix.
  • Documented evidence, not just document volume.

    Good CSV produces just enough documentation, in usable electronic forms to support objective evidence, scaled to risk.

Why CSV matters in pharma manufacturing

Computerized systems aren’t a peripheral concern in pharma manufacturing. They’re embedded in the processes that determine product quality and patient safety.

  • Patient safety.

Systems like MES enforce process parameters and sequence controls that keep a batch within its validated state.

  • Data integrity.

Electronic Batch Records, lab results, and audit trails are only as trustworthy as the systems that generate them, verified against ALCOA+ principles.

  • Regulatory readiness.

Validation gaps are serious findings in GMP inspections, requirements under the US 21 CFR’s and EU Annex 11 are checked in detail during audits under international GMP’s.

  • Operational continuity.

Change control and periodic review keep a system in a validated state as it’s patched and updated.

  • Cost avoidance.

Fixing a validation gap after deployment is far more expensive than catching it during validation.

Where traditional CSV goes wrong

  • IQ/OQ/PQ applied indiscriminately

to every system regardless of GxP criticality, producing excessive documentation for low-risk functions.

  • Duplicated testing

of functionality a qualified supplier has already verified, adding cost without adding compliance value.

  • Static documentation in a dynamic world,

forcing modern agile/SaaS delivery into rigid waterfall validation templates.

  • Treating documentation as the goal

rather than the proof, leading to over-documentation of low-risk areas and under-testing of real risk.

A modern, risk-based approach to CSV

Regulatory thinking has moved decisively toward proportionate, risk-based validation. The FDA’s Computer Software Assurance (CSA) initiative aims to reduce non-value-added documentation and testing while maintaining or improving actual assurance.

GAMP 5 Second Edition reflects the same shift, recognizing agile and iterative development as valid delivery models.

  • Start with a process and risk assessment

to determine GxP criticality and data vulnerability for each function.

  • Scale testing to risk level

scripted testing for high-risk functions, exploratory or unscripted testing for low-risk ones.

  • Leverage supplier qualification

rather than duplicating it, focusing user effort on configuration and intended use.

  • Maintain validated status operationally

through change control, periodic review, and access control SOPs.

Best practices for CSV implementation

  • Assess risk before you plan testing, not after.
  • Engage suppliers early and assess their SDLC, not just their software.
  • Define ownership clearly in formal agreements (Quality Agreements, SLAs, Validation Plan).
  • Match the test approach to the risk level.
  • Build validation into change control from day one.
  • Keep documentation traceable and audit-ready continuously, not just before an inspection.
  • Train the people operating the system, not just the system itself.

Conclusion

CSV exists to answer one question with confidence: can this system be trusted to do what it’s supposed to do, accurately and reliably, all the time? In pharma manufacturing, that question matters because the answer determines whether product quality, patient safety, and the integrity of GxP records can be relied upon.

A modern, risk-based approach, aligned with GAMP 5 Second Edition and the FDA’s Computer Software Assurance initiative, refocuses CSV on what actually matters: scoping testing effort to GxP criticality and data risk, leveraging supplier qualification where it’s already been done, and maintaining validated status throughout a system’s operational life not just proving it on day one.

Computer System Validation (CSV) Services

Implementing a compliant CSV strategy requires both regulatory expertise and practical experience. Factorytalk’s Computer System Validation (CSV) services help pharmaceutical, biotechnology, and medical device manufacturers validate computerized systems in accordance with GAMP 5, FDA 21 CFR Part 11, EU Annex 11, and international GMP requirements.

Our validation consultants support the complete system lifecycle, including:

  • CSV strategy and validation planning
  • Risk assessments and GxP impact analysis
  • User Requirements Specification (URS) development
  • Validation documentation (IQ, OQ, PQ, or modern CSA-based approaches)
  • Cloud software and MES validation
  • Data Integrity (ALCOA+) assessments
  • Periodic review and maintaining the validated state
  • Supplier assessment and leveraging vendor validation documentation

Whether you are deploying a new digital manufacturing solution or modernising existing validated systems, Factorytalk delivers practical, risk-based validation that reduces project timelines while maintaining regulatory compliance and audit readiness.

Learn more about our Computer System Validation (CSV) services, or contact our team to discuss how a tailored validation strategy can support your digital transformation and GMP compliance journey.